Here is additional evidence against Full Spectrum CBD, also straight from the FDA website, that The House’s CBD Legalization Bill won’t fix
Everybody knows about Epidiolex (CBD)
But few talk about Marinol and Syndros (THC) — that’s where the drug exclusion clause for THC first comes into play
And then it comes into play again a little bit later with Sativex, which utilizes a combination of CBD + THC
Taken directly from FDA website:
11. In making the two previous determinations about THC, why did FDA conclude that THC is an active ingredient in a drug product that has been approved under section 505 of the FD&C Act? In making the two previous determinations about CBD, why did FDA determine that substantial clinical investigations have been authorized for and/or instituted, and that the existence of such investigations has been made public?
A. THC (dronabinol) is the active ingredient in the approved drug products, Marinol capsules (and generics) and Syndros oral solution. CBD is the active ingredient in the approved drug product, Epidiolex.
The existence of substantial clinical investigations regarding THC and CBD have been made public. For example, two such substantial clinical investigations include GW Pharmaceuticals’ investigations regarding Sativex.
Sleek
